| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
44,696,000 |
| Market
Cap: |
11.62(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.156 - $0.62 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Tenax Therapeutics is focused on identifying, developing and commercializing late-stage pharmaceutical therapeutic products for serious cardiovascular and pulmonary diseases. Co. owns a license granting Life Newco, Inc., its wholly owned subsidiary, a sublicensable right to develop and commercialize pharmaceutical products containing levosimendan. Co.'s programs include: TNX-103 and TNX-102 (levosimendan), a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and TNX-201(imatinib), a tyrosine kinase inhibitor, which changed the treatment of chronic myeloid leukemia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rich Stuart |
Chief Medical Officer |
• • • |
2022-09-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,909,585 |
1,909,585 |
|
- |
|
| Rich Stuart |
Chief Medical Officer |
• • • |
2022-09-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,909,585 |
424,347 |
|
- |
|
| Doogan Declan |
|
• • • |
2022-08-11 |
4 |
GA |
$0.00 |
$0 |
D/D |
567,871 |
3,637,871 |
|
- |
|
| Doogan Declan |
|
• • • |
2022-08-11 |
4 |
GD |
$0.00 |
$0 |
I/I |
567,871 |
0 |
|
- |
|
| Rich Stuart |
Chief Medical Officer |
• • • |
2021-11-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,909,585 |
1,909,585 |
|
- |
|
| Rich Stuart |
Chief Medical Officer |
• • • |
2021-11-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,909,585 |
0 |
|
- |
|
| Rich Stuart |
Chief Medical Officer |
• • • |
2021-10-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,909,585 |
1,909,585 |
|
- |
|
| Rich Stuart |
Chief Medical Officer |
• • • |
2021-10-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,909,585 |
2,333,932 |
|
- |
|
| Doogan Declan |
|
• • • |
2021-06-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
567,871 |
2,502,129 |
|
- |
|
| Rich Stuart |
Chief Medical Officer |
• • • |
2021-06-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,581,000 |
4,243,517 |
|
- |
|
| Davidson Michael H. |
|
• • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
512,000 |
606,645 |
|
- |
|
| Doogan Declan |
|
• • • |
2021-06-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,070,000 |
3,637,871 |
|
- |
|
| Doogan Declan |
|
– • – |
2021-02-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,070 |
|
-13% |
|
| Doogan Declan |
|
– • – |
2021-02-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
567,871 |
|
-13% |
|
| Davidson Michael H. |
|
– • – |
2021-02-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
512 |
|
-13% |
|
| Davidson Michael H. |
|
– • – |
2021-02-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
96,645 |
|
-13% |
|
| Rich Stuart |
Chief Medical Officer |
• • – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,581 |
3,581 |
|
- |
|
| Rich Stuart |
Chief Medical Officer |
• • – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
662,517 |
662,517 |
|
- |
|
| Boyd Steven |
Director |
– • • |
2020-09-08 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
2,019,995 |
2.17 |
71% |
|
| Boyd Steven |
Director |
– • • |
2020-09-08 |
4 |
B |
$1.46 |
$12,473 |
D/D |
8,543 |
2,019,995 |
3.92 |
71% |
|
| Boyd Steven |
Director |
– • • |
2020-09-04 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
2,011,452 |
2.17 |
61% |
|
| Boyd Steven |
Director |
– • • |
2020-09-04 |
4 |
B |
$1.41 |
$33,074 |
D/D |
23,457 |
2,011,452 |
3.92 |
61% |
|
| Boyd Steven |
Director |
– • • |
2020-09-03 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,987,995 |
2.17 |
28% |
|
| Boyd Steven |
Director |
– • • |
2020-09-03 |
4 |
B |
$1.39 |
$50,040 |
D/D |
36,000 |
1,987,995 |
3.92 |
28% |
|
| Boyd Steven |
Director |
– • • |
2020-09-02 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,951,995 |
2.17 |
25% |
|
80 Records found
|
|
Page 1 of 4 |
|
|
